Covalon Technologies Ltd.

Research Covalon Technologies Ltd. (COV) on Bullrun: market cap CAD 63.52M, P/E 46.0, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 63.52M; P/E is 46.0; dividend yield is 5.1%.

Peer valuation comparison

Latest P/E is 46x versus a Healthcare sector median of 24.46x (88.1% above).

Latest dividend yield is 5.08% versus a Healthcare sector median of 2.11% (140.8% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 31.54MCAD 977.42KCAD 6.54M52.3%n/aCAD 17.88MCAD 2.07MCAD 26.39M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23CAD 63.52M46.0n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD, yield 5.1%.

About Covalon Technologies Ltd.

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Covalon Technologies Ltd.'s market cap?

Covalon Technologies Ltd.'s market capitalization is CAD 63.52M.

What is Covalon Technologies Ltd.'s P/E ratio?

Covalon Technologies Ltd.'s price-to-earnings (P/E) ratio is 46.0.

Does Covalon Technologies Ltd. pay a dividend?

Covalon Technologies Ltd. has a dividend yield of 5.1%.

What does Covalon Technologies Ltd. do?

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.